Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies
- 25 May 2000
- journal article
- Published by Elsevier in Neuroscience
- Vol. 97 (3) , 521-530
- https://doi.org/10.1016/s0306-4522(00)00020-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Replicating Huntington's disease phenotype in experimental animalsProgress in Neurobiology, 1999
- Metabolic Compromise with Systemic 3-Nitropropionic Acid Produces Striatal Apoptosis in Sprague–Dawley Rats but Not in BALB/c ByJ MiceExperimental Neurology, 1998
- Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatumNeuroscience, 1998
- Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in RatJournal of Neurochemistry, 1998
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.Proceedings of the National Academy of Sciences, 1995
- Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acidJournal of Neuroscience, 1993
- Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic AcidJournal of Neurochemistry, 1993
- Alternative excitotoxic hypothesesNeurology, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992